To view the complete agenda and full line up of speakers & their presentations please download the agenda to your right.

In keeping with Oxford Global’s highly successful R&D series, the topics for our established Biomarker’s congress have been compiled as a result of a comprehensive research process undertaken with an expert panel of advisory board members including Directors, Heads of Departments and Professors from global pharmaceutical organisations and leading academic research institutions

Gain insights from over 55 presentations, case studies, novel technologies, round-table and panel discussions focused on the opportunities and challenges of biomarker research discovery and development in a variety of therapeutic areas such as immune-oncology, neuroscience and cardio vascular disease areas, precision medicine, companion diagnostics, data integration methods, and utilising biomarkers in clinical trials

13th Annual Biomarkers Congress

Day 1 Stream 1 – Biomarkers in Drug Discovery & Development Therapeutic Areas: Autoimmune, Immuno-oncology, Neuroscience, Oncology

• Neurodegenerative disorder diagnosis and therapeutic drug development
• Safety, efficacy and PK/PD biomarkers in drug development
• Updates in predictive biomarkers for drug development
• Check point inhibitors and dual therapies in immuno-oncology
• Biomarker verification and validation
• Translational biomarkers and patient stratification

Day 1 Stream 2 – Precision Medicine, Companion Diagnostics, Molecular Diagnostics Development

• New developments of pharma and Dx manufacturer partnering strategies for CDx registration in ROW territories
• Reimbursement, stakeholders for regulatory approval
• Innovative trial design, precision medicine and companion diagnostics development
• Development of companion/complementary diagnostics
• Computational modelling to improve diagnostics
• Companion complementary Dx for liquid biopsies and cancer immunotherapy

Day 2 Stream 1 – Biomarkers in Drug Discovery & Development Therapeutic Areas: Cardiovascular, Rheumatology, Respiratory, COPD, Rare Diseases, Infectious Diseases, Inherited Diseases

• Advances in novel biomarker discovery & identification
• Safety, efficacy and PK/PD biomarkers in drug development
• New trends of predictive biomarkers for drug development
• Respiratory diseases: inflammatory biomarkers
• Translational biomarkers and patient stratification

Day 2 Stream 2 – Innovations in Biomarkers Research, Assay Development, Imaging, Data Integration Methods, Bioinformatics, Trial Design

• Human protein atlas for novel biomarkers Identification
• Immuno-assays and screening processes
• Nanotechnology for bioinformatics
• Predictive biomarkers for targeting therapy
• Big data analytics and sampling techniques
  – Downstream analysis and integration
  – Cloud solutions, ethics, biobanking
• New advances in biomarker technologies and platforms in assay development
• Artificial intelligence tools for biomarkers
• Insights into population genetics, systems biology, data analytics
• Imaging technologies, CNS imaging techniques, digital pathology

5th Annual Biomarker in Clinical Development Congress

Day 1 Stream 3 – Biomarkers: Clinical Development & Clinical Trials

• Robustness of translation of pre-clinical to clinical: quality control and validation
• Surrogate endpoints: utilising biomarkers in clinical trials
• PK/PD biomarkers to clinical biomarkers
• Implementing clinical biomarker in auto-immune diseases, cardiovascular, COPD, immuno-oncology, inflammatory
• Transforming clinical development through biomarker driven clinical trials design
• Recent developments of predictive biomarker discovery in proof

Day 2 Stream 3 – Innovative Biology – NGS & Genomic Markers, Clinical Testing and Diagnostics Development

• NGS for clinical testing & diagnostics
  – Partnering strategies
• Epigenomic biomarkers
• Predictive biomarkers: DNA and microRNA’s
• Genomic approaches in drug development
  – Bio sequencing
  – DNA synthesis
• Advances made in NGS techniques in liquid biopsy
• RNAseq NGS in biomarker benchmarking